Janet Woodcock, former FDA official, joins board of patient group focused on ‘rediscovering’ old drugs

Taking stock of the drug industry, from the lab to the medicine chest

October 7, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Stefani Reynolds-Pool/Getty Images STAT+ | Janet Woodcock, former FDA official, joins board of patient group focused on 'rediscovering' old drugs Every Cure, led by physician David Fajgenbaum, is scouring thousands of existing drugs to see if any can cure hard-to-treat diseases. By Matthew Herper STAT+ | 12 people changing the course of the Chinese biopharma industry STAT profile series on key players in life sciences looks at the 12 top players in Chinese biotechnology, from researchers to pharma corporate executives. By Brian Yang STAT+ | Scholar Rock drug for spinal muscular atrophy succeeds in late-stage study In a year-long Phase 3 trial, the company tested the drug, called apitegromab, on top of existing treatments for the disease. By Elaine Chen JONATHAN NACKSTRAND/AFP via Getty Images 2024 Nobel prize in medicine: Ruvkun, Ambros win for discovery of microRNA The prize went to the two researchers for their discovery of microRNA, which plays a crucial role in regulating gene activity. By Andrew Joseph

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser